# Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery

> **NCT02222129** · PHASE4 · COMPLETED · sponsor: **Knight, Richard, M.D.** · enrollment: 206 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** liposomal bupivacaine

## Key facts

- **NCT ID:** NCT02222129
- **Lead sponsor:** Knight, Richard, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02222129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02222129, "Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02222129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*